Most drug pricing articles are really articles about generics. Qelbree is not one of those. Viloxazine extended-release has been on the U.S. market since 2021 and there is still no generic version approved, which means there is no cheap parallel product waiting to rescue your budget.
That changes what “how to pay less” even means here. Every figure below was researched fresh on September 3, 2026, and the useful question is not which pharmacy shaves ten dollars off a four-hundred-dollar fill. It is whether you can get onto the manufacturer’s own programs, because that is where the entire spread lives.
What Does Qelbree Cost Without Insurance?
Acquisition costs come from the CMS National Average Drug Acquisition Cost survey, the federal file that records what pharmacies actually pay wholesalers. The Qelbree rows are effective August 19, 2026. Retail cash prices come from the Drugs.com price guide, read September 3, 2026. The two agree closely, which is the strongest signal you get in drug pricing.
| Option | Low | Average | High |
|---|---|---|---|
| CMS NADAC acquisition cost, one capsule | $12.73227 (100 mg) | $12.73390 (150 mg) | $12.74046 (200 mg) |
| CMS NADAC, 30-capsule month at acquisition cost | $381.97 | $382.02 | $382.21 |
| Retail cash price, 30 capsules (any strength) | $398.76 | $398.76 | $398.76 |
| Retail cash price, 60 capsules of 200 mg | $789.62 | $789.62 | $789.62 |
| Manufacturer savings card, per prescription | $20.00 | varies | varies |
| Generic viloxazine, 30 capsules | not available | not available | not available |
Two things stand out. First, the gap between what a pharmacy pays and what you pay is about $17 on a $399 fill, roughly 4%. There is very little pharmacy margin to negotiate away. Second, the strengths are priced identically to the tenth of a cent, so the dose you were prescribed has essentially no effect on your bill.
What Drives the Price
There is no generic. As of September 3, 2026, the FDA’s Drugs@FDA database returns exactly one application for viloxazine: NDA 211964, held by Supernus Pharmaceuticals, covering the 100 mg, 150 mg and 200 mg extended-release capsules. No abbreviated new drug application appears, and CMS’s acquisition-cost survey has brand Qelbree rows and no generic viloxazine rows at all. Until an ANDA is approved and launched, there is no second seller to compete the price down.
Flat per-capsule pricing. Qelbree is billed by the capsule regardless of strength. That is why the 100 mg and 200 mg cost the same. It also means a dose change does not change your monthly cost, which is unusual. On most generics, going from a low strength to a high one raises the bill.
Quantity discounts barely exist. A 60-capsule fill of the 200 mg costs $789.62 against $797.52 for two separate 30-capsule fills. That is a saving of about $7.90, or 1%. Compare that to a common generic, where a 90-day fill often costs a third of three monthly fills.
Pharmacy markup is thin but the base is high. The retail cash price sits roughly 4% above acquisition cost. On a $10 generic that markup is invisible. On Qelbree it is about $17, which is real money but nowhere near the size of the underlying price.
No retail program covers it. Walmart’s Prescription Program drug list, effective March 24, 2025 and read September 3, 2026, does not include viloxazine at any of its three tiers ($4/$10, $9/$24 or $15/$38). That program is built around cheap multi-source generics, and a brand-only capsule does not qualify.
Cash Price vs. Insurance
For most of the drugs on this site, paying cash sometimes beats running a claim. Qelbree is the clearest case where it usually does not. At roughly $399 a month, almost any commercial plan’s copay or coinsurance will land below the cash price, and if you have coverage, running the claim and stacking the manufacturer savings card on top is the cheapest path.
The wrinkle is prior authorization. Non-stimulant ADHD medications with no generic are a standard target for utilization management, and a denied or pending prior authorization can leave you facing the full cash price for weeks. That is exactly the window where the savings card matters most, because the card’s own terms extend to cash-paying patients rather than only to patients with an active covered claim.
If you are uninsured, the cash price is the starting point, not the finish line. Work through the programs below before you pay $398.76 out of pocket. And if a pharmacy quotes you well above that figure, treat it as a signal to call two more pharmacies rather than an accurate market price. Our fair price checker is a quick sanity check on any quote you get.
How to Pay Less
1. Read the savings card terms yourself, then use it. Supernus advertises the Qelbree Savings Card as letting commercially insured patients pay as little as $20 per prescription. The terms and conditions published on the manufacturer’s cost and savings page go further than the headline: they state the offer is good for most commercially insured and cash-paying patients. That is genuinely unusual. Most manufacturer cards in this category exclude uninsured cash payers outright. The exclusions here are Medicaid, Medicare and other federal or state programs, and the terms add that maximum benefits and quantity limits may apply. Download and activate the card before you go to the pharmacy, and confirm the actual out-of-pocket at the counter before you hand over payment.
2. Call Supernus Support about patient assistance. The company runs copayment assistance, patient support and patient assistance programs, with eligibility determined case by case rather than against a published income cutoff. The number listed is 1-866-398-0833, staffed Monday through Friday, 8:30 AM to 6:30 PM Eastern. Because there is no published income threshold, an uninsured applicant who assumes they will not qualify has no way of knowing that without calling. This is the single highest-value phone call on this page.
3. Ask your prescriber about samples. The manufacturer’s own patient site says providers can request Qelbree samples for their office and that patients can ask for one in person or during a telemedicine visit. Samples will not carry you month to month, but they can cover a gap while a prior authorization or an assistance application is pending.
4. Shop the discount cards, but set expectations. Supernus’s own cost page points cash payers to GoodRx and Amazon Pharmacy for online purchasing. Discount cards work on brand drugs, but the discounts are proportionally much smaller than on generics because there is no competing supply to arbitrage. Compare a few before you fill, and see our breakdown of GoodRx vs. SingleCare for how the cards actually differ.
5. Use a community health center for the prescribing visit. The medication is only half of an ADHD budget. Federally qualified health centers and sliding-scale clinics charge on income for the office visits and the follow-ups, which is often where the recurring costs stack up. See free clinics and sliding-scale care for how to find one, and our guide to psychiatrist costs for what those visits run at market rates.
6. If a pharmacy bill has already gone unpaid, deal with it directly. A single missed brand fill does not usually go to collections, but an ADHD care plan that includes testing and specialist visits can generate hospital or clinic bills that do. Our guide to negotiating medical bills covers what to say and when.
How Qelbree Compares in the ADHD Cluster
Qelbree sits at the expensive end of ADHD pricing, and it is worth knowing where the other options land before you fill. Generic guanfacine, the other widely used non-stimulant, was quoted on the same September 2026 Drugs.com price guide at $16.22 for 30 of the 1 mg tablets, and generic guanfacine extended-release at $28.19 to $50.17 per 100 tablets. That is roughly a 25-fold difference against Qelbree’s $398.76 for 30.
Our other cluster pages cover the rest of the field: guanfacine cost for the cheapest non-stimulant, Strattera cost for atomoxetine, and Vyvanse, Concerta and Ritalin for the stimulants. If you have not been diagnosed yet, ADHD testing cost covers the evaluation side.
None of this is a recommendation about what to take. Which medication is right is a clinical decision between you and your prescriber, and price is only one input. What you can do with the numbers is walk into that conversation knowing what each option would cost you at the counter.
The Bottom Line
Qelbree costs $382 to $399 for a 30-capsule month as of September 2026, and the price barely moves across strengths, quantities or pharmacies. That flatness is the whole story: with no generic viloxazine approved and only about 4% of the price sitting in pharmacy markup, there is very little to shop for.
The money is in the programs instead. The savings card’s terms cover cash-paying patients as well as the commercially insured, and Supernus runs a case-by-case assistance program with no published income cutoff. Those two routes are worth an hour of phone calls before you accept a $398.76 monthly bill.